Catherine Diefenbach, MD

Assistant Professor of Medicine
Clinical Director of Lymphoma
Department of Hematology/Oncology
NYU Langone Medical Center
New York, New York

Dr. Catherine Diefenbach received her medical degree from the University of Pennsylvania School of Medicine. She completed her internship and residency at the Johns Hopkins Hospital and her oncology fellowship at Memorial Sloan Kettering Cancer Center, where she spent an additional year focusing on translational immunology. Dr. Diefenbach is an Assistant Professor of Medicine, and the Clinical Director of Lymphoma in the Department of Hematology/Oncology at the NYU Langone Medical Center and a member of its Laura and Isaac Perlmutter Cancer Center. Additionally, she directs the lymphoma clinical research within the Hematology Division at the Perlmutter Cancer Center.

Dr. Diefenbach serves on the ECOG Lymphoma Committee, the Grants Committee of the ASCO Conquer the Cancer Foundation, the ASH Communications Committee, and is on the editorial board of Clinical Cancer Research. She is a translational physician-scientist specializing in the care of patients with Hodgkin and non-Hodgkin lymphoma, whose research is supported by the American Cancer Society, the National Cancer Institute (NCI), and the Doris Duke Foundation, and previously by the Lymphoma Research Foundation. Dr. Diefenbach’s scientific research focuses on the relationship between lymphoma and immunity; on developing novel and immune based treatment strategies for patients with relapsed lymphoma; and on biomarker discovery. 

Last modified: November 26, 2018

MediCom Worldwide, Inc. would like to recognize and thank Bristol-Myers Squibb, Merck & Co., Inc., and Seattle Genetics for their educational support. To better serve the needs of our audience, is now

©2020 MediCom Worldwide, Inc. All rights reserved